Thursday, February 09, 2006

Methylphenidate

From The New York Times:
Panel Recommends Warnings for Ritalin and Other Stimulants
By THE ASSOCIATED PRESS
Published: February 9, 2006
Filed at 4:13 p.m. ET

WASHINGTON (AP) -- Federal science advisers voted narrowly Thursday to recommend the most serious type of warning labels for Ritalin and other stimulants that are used to treat attention deficit hyperactivity disorder.

The 8-7 vote, with one abstention, by the Food and Drug Administration committee was to recommend adding ''black box'' safety warnings to ADHD drugs. Doctors prescribe the increasingly popular drugs to about 2 million children and 1 million adults a month.

The FDA isn't required to follow the recommendations of its advisory committees but typically does.

[...continues...]
[ ... Read the full article ... ]
-
Anthony H. Risser | |

0 Comments:

Post a Comment

<< Home